Therapeutic drug monitoring (TDM) is a process that involves monitoring the levels of drugs in the body to ensure that they remain within a therapeutic range.
The amount of milliliters to be given to the patient can be determined by the Body Surface Area (BSA) of a 44 lb dog in m2 and the concentration of the drug (2 mg/mL).
The steps of the target concentration strategy in TDM include setting a target concentration, determining the initial dose, and monitoring the patient's response.
The dose is divided by the amount (concentration) of the drug in the pharmaceutical form (e.g., tablet or solution) to determine the actual amount of the pharmaceutical form to be administered.
If the order is to just give a dog 300 mg of amoxicillin, then the ordered amount is simply divided by the concentration of the to determine the amount to be administered.
If a 20-kg dog is to be given amoxicillin at the rate of 10 mg/kg and injectable amoxicillin at a concentration of 100 mg/mL is available, the dosage calculation would be as follows:
A conservative approach to dosage adjustment is to increase the dose incrementally, starting with a dose of 400 mg/day and increasing the dose to 500 mg/day.
If a patient has drug concentrations outside the therapeutic range, the dose should be modified to change the drug concentrations into the therapeutic range by a proportional adjustment.